INLYTA®
(in-ly-ta)
(Axitinib)

Chemotherapy 

INLYTA®
(in-ly-ta)
(Axitinib)

Chemotherapy

What is INLYTA (Axitinib)?

INLYTA is a prescription medicine used to treat advanced kidney cancer (advanced renal cell carcinoma or RCC) when one prior drug treatment for this disease has not worked.

It is not known if INLYTA is safe or effective in children.

What is the most important information I should know about INLYTA?

INLYTA can cause serious side effects. These serious side effects include:

How should I take INLYTA?

Nucleic Acid Diagnostic kit

Important Safety Information

Ask your healthcare provider if you do not know.

What should I tell my healthcare provider before taking INLYTA?

Before you take INLYTA, tell your doctor if you:

Tell your doctor about all the medicines you take, including prescription and non-prescription medicines, vitamins, and herbal supplements.

Available 24/7
Experiencing
symotoms that
concern you

General information about INLYTA

Medicines are sometimes prescribed for purposes other than those listed in a Patient Information leaflet. Do not use INLYTA for a condition for which it was not prescribed. Do not give INLYTA to other people, even if they have the same symptoms you have. It may harm them.

What are the ingredients in INLYTA?

Active ingredient: Axitinib

Other ingredient: Microcrystalline cellulose, lactose monohydrate, croscarmellose sodium, magnesium stearate, and Opadry® II red 32K15441. The Opadry II red 32K15441 film coating contains: lactose monohydrate, HPMC 2910/Hypromellose 15cp, titanium dioxide, triacetin (glycerol triacetate), and red iron oxide.

Have questions about chemotherapy?

Contact for Second Opinion or Free Counselling

Available 24/7
Experiencing
symotoms that
concern you
Have questions
about cancer?
Just ask Alexa. Find voice-activated answers to 800+ questions on 40+ cancer types.